Document is current
Any future updates will be listed below
-
Authors
Nagare, Manasi
Sahoo, Monalisa
Sengar, Manju
Punatar, Sachin
Khattry, Navin
Gokarn, Anant
Bagal, Bhausaheb
Jain, Hasmukh
Mirgh, Sumeet
Epari, Sridhar
Shet, Tanuja
Pradhan, Trupti
Shirsat, Shweta
Barkume, Madan
Mathen, Caroline
Gera, Poonam
Verma, Rohit Kumar
Saldanha, Elveera
Chandrani, Pratik
Gawde, Jitendra
Chiplunkar, Shubhada
Kode, Jyoti
-
Funding
Funding for this research was provided by:
TATA MEMORIAL CENTRE - TRAC (TRAC/0823/900561/001)
Indian Council of Medical Research (53/13/2013/CMB/BMS)
Department of Atomic Energy, Government of India (1/3(7)/2020/TMC/ R&D-II/8823)
- License Information
-
More Information
Article History
Received: 17 September 2025
Accepted: 3 December 2025
First Online: 23 February 2026
Declarations
:
: The authors declare no conflict of interests.
: Collection and processing of bone marrow samples of AML and NHL patients and peripheral blood from healthy individuals were in accordance with the procedures approved by the human ethics committee of Tata Memorial Centre (IEC-III approved studies #100 and #900561). All procedures involving mice were performed in accordance with the protocols approved by the Institutional Animal Ethics Committee, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai (IAEC Approval proposal #43/2022), and adhered to CCSEA guidelines (Registration Number: 65/GO/ReBiBt/S/99/CCSEA).
